13F filing recap · Q4 2022

What did Patient Capital Management buy in Q4 2022?

Reported stock-position changes between this filing and the previous one.

Stock value

$204.15M

Positions

Estimated turnover

14.0%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

SISilvergate Capital Corporation$2.36Mreported value+135.6K shares FTCHFarfetch Limited$1.51Mreported value+2.00M shares PTONPeloton Interactive, Inc.$794.0Kreported value+100.0K shares

Increased positions

EXPEExpedia Group, Inc.$11.57Mreported value+5.8K shares+4.6%GOOSCanada Goose Holdings Inc.$6.66Mreported value+199.8K shares+114.9%NCLHNorwegian Cruise Line Holdings Ltd.$6.16Mreported value+37.9K shares+8.1%JPMJPMorgan Chase & Co$6.10Mreported value+1.1K shares

Reduced positions

OVVOvintiv Inc.$12.70Mreported value-7.5K shares-2.9%ETEnergy Transfer LP$8.78Mreported value-21.6K shares-2.8%BABAAlibaba Group Holding Limited$7.78Mreported value-3.7K shares-4.0%TEVATeva Pharmaceutical Industries Limited$7.59Mreported value-342.4K shares

Exited positions

BHCBausch Health Companies Inc.$1.29Mprior reported value-187.6K shares-100.0%BRLTBrilliant Earth Group, Inc.$430.0Kprior reported value-75.0K shares-100.0%